Agreed
There is a case for some “out of the blue” financial event due the the end of fiscal year. Some of our big friends operate there FY aligned to the calendar year. There is also a possibility that GSK will share further IMP731 results. Those Short would no doubt be considering the plausibility of a deal. Those undertaking due diligence anyway. Just my musings. GLTA.
Agreed There is a case for some “out of the blue” financial...
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.025(8.77%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 31.0¢ | 29.0¢ | $960.3K | 3.208M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1353 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 36123 | 3 |
View Market Depth
| Last trade - 15.59pm 22/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
